4.2 Synchronized Cardioversion Indications, Energy Doses & Sync Mechanics

Synchronized Cardioversion Indications, Energy Doses & Sync Mechanics

Synchronized cardioversion is a life-saving, time-critical intervention in the ACLS Tachycardia Algorithm. It involves the delivery of a precisely timed electrical shock to the heart to terminate a dangerous tachyarrhythmia and restore normal sinus rhythm. Understanding when to use it, how it works, and the correct energy settings is fundamental to effective resuscitation.

Indications for Immediate Synchronized Cardioversion

The primary indication for synchronized cardioversion is the presence of an unstable tachycardia with a pulse. As established in the initial assessment, instability is defined by the presence of at least one of the following signs directly caused by the rapid heart rate:

• Hypotension
• Acutely altered mental status
• Signs of shock
• Ischemic chest discomfort
• Acute heart failure

If a patient presents with a tachyarrhythmia and demonstrates any of these signs, pharmacological interventions are generally bypassed in favor of immediate electrical cardioversion. The rationale is that electrical cardioversion is the fastest and most reliable method to terminate the arrhythmia and restore adequate cardiac output. Delaying cardioversion to trial medications in an unstable patient can lead to further deterioration and potentially cardiac arrest.

The Mechanics of Synchronization

The crucial difference between defibrillation (used in cardiac arrest) and synchronized cardioversion is the timing of the electrical discharge.

In synchronized cardioversion, the defibrillator is placed in "Sync" mode. The device's internal computer analyzes the patient's ECG rhythm and identifies the highest amplitude electrical signal, which is typically the R-wave of the QRS complex (representing ventricular depolarization).

The 'Sync' feature ensures that the shock is delivered exactly on, or immediately after, the peak of the R-wave.

Why is Synchronization Essential?

Synchronization is necessary to avoid the "R-on-T phenomenon." The T-wave on the ECG represents ventricular repolarization. The peak and descending limb of the T-wave constitute the "relative refractory period" of the cardiac cycle. During this brief window, a portion of the ventricular myocardium has repolarized while other areas have not.

If a high-energy electrical shock is delivered during this vulnerable period, it can precipitate chaotic, disorganized electrical activity, instantly converting the patient's rhythm into ventricular fibrillation (VF). By synchronizing the shock to the R-wave, the defibrillator guarantees that the energy is delivered during the absolute refractory period (when the ventricles cannot be stimulated), effectively bypassing the dangerous T-wave phase.

It is imperative to verify that the defibrillator is actively "flagging" or marking each R-wave on the monitor screen before delivering the shock. If the device cannot identify the R-waves (e.g., due to low amplitude or artifact), synchronization will not occur properly.

Recommended Initial Energy Doses

The energy required for successful cardioversion depends on the specific morphology of the tachyarrhythmia. The ACLS guidelines recommend different initial energy levels, typically using biphasic defibrillators, based on whether the rhythm is narrow or wide, and regular or irregular.

1. Narrow Regular Tachycardia (e.g., SVT, Atrial Flutter)

• Initial Dose: 50 to 100 Joules (biphasic).
• Rationale: These rhythms originate above the ventricles and generally require less energy to terminate. Atrial flutter, in particular, is often very sensitive to electrical cardioversion and may convert at lower energies (e.g., 50 J), whereas AV nodal reentrant tachycardias (SVT) might require slightly more.

2. Narrow Irregular Tachycardia (e.g., Atrial Fibrillation)

• Initial Dose: 120 to 200 Joules (biphasic).
• Rationale: Atrial fibrillation involves multiple chaotic micro-reentrant circuits within the atria. Terminating these numerous circuits requires significantly higher energy than a single reentrant circuit seen in regular tachycardias.

3. Wide Regular Tachycardia (e.g., Monomorphic Ventricular Tachycardia)

• Initial Dose: 100 Joules (biphasic).
• Rationale: Monomorphic VT, while originating in the ventricles, has a consistent, organized morphology. A synchronized shock of 100 J is typically sufficient to interrupt the reentrant circuit in the ventricles.

4. Wide Irregular Tachycardia (e.g., Polymorphic VT / Torsades de Pointes)

• Crucial Exception: This rhythm is managed differently. Because the QRS complexes vary constantly in shape and amplitude, the defibrillator's sync mechanism cannot reliably track a consistent R-wave. Attempting to synchronize on polymorphic VT often fails, delaying therapy, or risks shocking on a T-wave.
• Treatment: Polymorphic VT should be treated as ventricular fibrillation. Do NOT use synchronized cardioversion. Immediately deliver an unsynchronized high-energy shock (defibrillation dose, typically 120-200 J biphasic or 360 J monophasic).

Sedation

Synchronized cardioversion is a painful procedure. For patients who are conscious, sedation and analgesia must be strongly considered.

Whenever feasible, administer appropriate sedatives (e.g., midazolam, propofol, or etomidate) and analgesics (e.g., fentanyl) before the procedure. However, the absolute rule is that sedation must never delay cardioversion in a patient who is rapidly deteriorating or immediately life-threatened. If the patient is profoundly hypotensive or unresponsive due to the arrhythmia, cardiovert immediately without waiting for sedation to take effect. If the patient is unstable but slightly more stable, a rapid push of a sedative is appropriate.